Ophthalmic acid

Ophthalmic acid is a tripeptide that is structurally similar to glutathione, differing only by the replacement of the cysteine residue with 2-aminobutyric acid. It was first isolated from the eyes of calfs, which is the origin of its name. Ophthalmic acid is believed to be a biomarker for oxidative stress, particularly in the context of eye health, but its presence and role have also been investigated in other tissues and conditions related to oxidative damage.

The synthesis of ophthalmic acid occurs through a similar pathway to glutathione, involving the enzyme glutamate-cysteine ligase (GCL) and glutathione synthetase (GS). However, the specific details of its biosynthesis and regulation in vivo remain less understood compared to glutathione.

In the context of medical research, the measurement of ophthalmic acid levels, alongside glutathione, can provide insights into the oxidative stress status of tissues. Elevated levels of ophthalmic acid have been associated with various pathological conditions, including liver disease, diabetes mellitus, and neurodegenerative diseases, suggesting its potential as a biomarker for these conditions.

Research into ophthalmic acid also extends into its potential therapeutic applications. Given its structural similarity to glutathione, there is interest in exploring ophthalmic acid as an antioxidant therapy, particularly for conditions where glutathione metabolism is disrupted. However, the efficacy and safety of such applications require further clinical investigation.

‎